Cargando…

The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum

INTRODUCTION: Despite women showing greater Alzheimer's disease (AD) prevalence, tau burden, and immune/neuroinflammatory response, whether neuroinflammation impacts cognition differently in women versus men and the biological basis of this impact remain unknown. We examined sex differences in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernier, Rachel A., Banks, Sarah J., Panizzon, Matthew S., Andrews, Murray J., Jacobs, Emily G., Galasko, Douglas R., Shepherd, Alyx L., Akassoglou, Katerina, Sundermann, Erin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973901/
https://www.ncbi.nlm.nih.gov/pubmed/35386474
http://dx.doi.org/10.1002/dad2.12284
_version_ 1784680145306517504
author Bernier, Rachel A.
Banks, Sarah J.
Panizzon, Matthew S.
Andrews, Murray J.
Jacobs, Emily G.
Galasko, Douglas R.
Shepherd, Alyx L.
Akassoglou, Katerina
Sundermann, Erin E.
author_facet Bernier, Rachel A.
Banks, Sarah J.
Panizzon, Matthew S.
Andrews, Murray J.
Jacobs, Emily G.
Galasko, Douglas R.
Shepherd, Alyx L.
Akassoglou, Katerina
Sundermann, Erin E.
author_sort Bernier, Rachel A.
collection PubMed
description INTRODUCTION: Despite women showing greater Alzheimer's disease (AD) prevalence, tau burden, and immune/neuroinflammatory response, whether neuroinflammation impacts cognition differently in women versus men and the biological basis of this impact remain unknown. We examined sex differences in how cerebrospinal fluid (CSF) neuroinflammation relates to cognition across the aging–mild cognitive impairment (MCI)–AD continuum and the mediating role of phosphorylated tau (p‐tau) versus other AD biomarkers. METHODS: Participants included 284 individuals from the Alzheimer's Disease Neuroimaging Initiative study. CSF neuroinflammatory markers included interleukin‐6, tumor necrosis factor α, soluble tumor necrosis factor receptor 2 (sTNFR2), and chitinase‐3‐like protein 1. AD biomarkers were CSF p‐tau(181) and amyloid beta(1‐42) levels and magnetic resonance imaging measures of hippocampal and white matter hyperintensity volumes. RESULTS: We found a sex‐by‐sTNFR2 interaction on Mini‐Mental State Examination and Clinical Dementia Rating‐Sum of Boxes. Higher levels of sTNFR2 related to poorer cognition in women only. Among biomarkers, only p‐tau(181) eliminated the female‐specific relationships between neuroinflammation and cognition. DISCUSSION: Women may be more susceptible than men to the adverse effects of sTNFR2 on cognition with a potential etiological link with tau to these effects.
format Online
Article
Text
id pubmed-8973901
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89739012022-04-05 The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum Bernier, Rachel A. Banks, Sarah J. Panizzon, Matthew S. Andrews, Murray J. Jacobs, Emily G. Galasko, Douglas R. Shepherd, Alyx L. Akassoglou, Katerina Sundermann, Erin E. Alzheimers Dement (Amst) Research Articles INTRODUCTION: Despite women showing greater Alzheimer's disease (AD) prevalence, tau burden, and immune/neuroinflammatory response, whether neuroinflammation impacts cognition differently in women versus men and the biological basis of this impact remain unknown. We examined sex differences in how cerebrospinal fluid (CSF) neuroinflammation relates to cognition across the aging–mild cognitive impairment (MCI)–AD continuum and the mediating role of phosphorylated tau (p‐tau) versus other AD biomarkers. METHODS: Participants included 284 individuals from the Alzheimer's Disease Neuroimaging Initiative study. CSF neuroinflammatory markers included interleukin‐6, tumor necrosis factor α, soluble tumor necrosis factor receptor 2 (sTNFR2), and chitinase‐3‐like protein 1. AD biomarkers were CSF p‐tau(181) and amyloid beta(1‐42) levels and magnetic resonance imaging measures of hippocampal and white matter hyperintensity volumes. RESULTS: We found a sex‐by‐sTNFR2 interaction on Mini‐Mental State Examination and Clinical Dementia Rating‐Sum of Boxes. Higher levels of sTNFR2 related to poorer cognition in women only. Among biomarkers, only p‐tau(181) eliminated the female‐specific relationships between neuroinflammation and cognition. DISCUSSION: Women may be more susceptible than men to the adverse effects of sTNFR2 on cognition with a potential etiological link with tau to these effects. John Wiley and Sons Inc. 2022-04-01 /pmc/articles/PMC8973901/ /pubmed/35386474 http://dx.doi.org/10.1002/dad2.12284 Text en © 2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Bernier, Rachel A.
Banks, Sarah J.
Panizzon, Matthew S.
Andrews, Murray J.
Jacobs, Emily G.
Galasko, Douglas R.
Shepherd, Alyx L.
Akassoglou, Katerina
Sundermann, Erin E.
The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum
title The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum
title_full The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum
title_fullStr The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum
title_full_unstemmed The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum
title_short The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum
title_sort neuroinflammatory marker stnfr2 relates to worse cognition and tau in women across the alzheimer's disease spectrum
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973901/
https://www.ncbi.nlm.nih.gov/pubmed/35386474
http://dx.doi.org/10.1002/dad2.12284
work_keys_str_mv AT bernierrachela theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT bankssarahj theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT panizzonmatthews theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT andrewsmurrayj theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT jacobsemilyg theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT galaskodouglasr theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT shepherdalyxl theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT akassogloukaterina theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT sundermannerine theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT theneuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT bernierrachela neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT bankssarahj neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT panizzonmatthews neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT andrewsmurrayj neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT jacobsemilyg neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT galaskodouglasr neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT shepherdalyxl neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT akassogloukaterina neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT sundermannerine neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum
AT neuroinflammatorymarkerstnfr2relatestoworsecognitionandtauinwomenacrossthealzheimersdiseasespectrum